SEC Filing Summary: SANUWAVE Health, Inc. (SNWV)
Business Context and Reporting Period
This Form 8-K was filed on April 16, 2026, by SANUWAVE Health, Inc., a Nevada corporation. The report serves to announce preliminary financial results for the quarter ended March 31, 2026. The company's common stock trades on The Nasdaq Stock Market LLC under the symbol SNWV.
Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The document acts as a notification that a press release containing these preliminary results has been issued and is attached as Exhibit 99.1, but the specific figures are not embedded within the body of this 8-K text.
Material Changes
No material changes versus the prior comparable period are detailed in this filing text. The document references the issuance of preliminary results but does not quantify year-over-year or quarter-over-quarter performance changes.
Guidance, Outlook, and Risks
The filing includes standard legal disclaimers stating that the information furnished in Item 2.02 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and shall not be incorporated by reference into other filings unless expressly stated. No specific management commentary, forward-looking guidance, or detailed risk factors are present in this text.
Key Facts for Investor Verification
- Verify the specific preliminary financial figures for the quarter ended March 31, 2026, by reviewing Exhibit 99.1 (Press Release) attached to this filing.
- Confirm the company's status as an emerging growth company, as the filing indicates this status but does not detail specific election choices regarding accounting standards in the text provided.
- Note that the financial data in this report is preliminary and subject to the limitations of the "furnished" status under the Exchange Act.